George Cole
Keine laufenden Positionen mehr
Karriereverlauf von George Cole
Ehemalige bekannte Positionen von George Cole
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | 24.06.2007 | 13.05.2008 |
| Vorstandsvorsitzender | 24.06.2007 | 13.05.2008 | |
| Geschäftsführer | 01.11.2005 | 24.06.2007 | |
| Präsident | 24.06.2007 | 13.05.2008 | |
ALTANA Pharma US, Inc.
 ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Präsident | 01.01.1992 | 01.01.2005 |
Ausbildung von George Cole
| University of Evansville | Masters Business Admin |
| University of Louisiana at Lafayette | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| President | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ALTANA Pharma US, Inc.
ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
- Börse
- Insiders
- George Cole
- Erfahrung
